Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
Sometimes caring for yourself starts with a simple step. Revilab SL 08 — to help you feel comfortable and full of energy every day!
Subscribe to mailing and get the latest news and discounts of our store.>
New brochure
Dear partners, colleagues and friends!
The Peptides company constantly participates in international events of the highest level, and we are pleased to present a new electronic brochure, which contains the abstracts of scientific reports that have received recognition in the world.
The reports contain impressive results of the use of peptide bioregulators for the prevention and complex treatment of certain diseases.
Peptides celebrates 6 years in Europe!
We are proud to celebrate this important milestone, which is the result of the diligence and dedication of our partners.
We are pleased to introduce you a new scientific lecture — «The effect of short peptides on brain functioning under normal and neurodegenerative conditions».
We are excited to introduce you brand new complex geroprotectors of a new type based on peptide extracts - GPL® Man and GPL® Femme - created as long joint ventures between Peptides and Saint-Petersburg Institute of bioregulation and gerontology.